DEEPNOID prepares to enter the Chinese market with 'DEEP: PHI,' an AI solution for medical image diagnosis support. Recently, DEEP: PHI is going through approval as a medical device under the Korea Food and Drug Administration. Embedded solutions include AI in compression fracture and cerebral aneurysm.
as soon as obtaining the medical device license, DEEP: PHI will expand onto China. The Alibaba cloud has completed its technical review to install in DEEP: PHI on their system. As early as the second quarter next year, DEEP: PHI will be supplied selectively to Alibaba-cooperated hospitals.